Prediction of drug adverse events using deep learning in pharmaceutical discovery

被引:46
|
作者
Lee, Chun Yen [1 ]
Chen, Yi-Ping Phoebe [1 ]
机构
[1] La Trobe Univ, Dept Comp Sci & Informat Technol, Melbourne, Vic, Australia
关键词
deep learning; pharmacovigilance; adverse drug reactions; INTERACTION EXTRACTION; NEURAL-NETWORKS;
D O I
10.1093/bib/bbaa040
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Traditional machine learning methods used to detect the side effects of drugs pose significant challenges as feature engineering processes are labor-intensive, expert-dependent, time-consuming and cost-ineffective. Moreover, these methods only focus on detecting the association between drugs and their side effects or classifying drug-drug interaction. Motivated by technological advancements and the availability of big data, we provide a review on the detection and classification of side effects using deep learning approaches. It is shown that the effective integration of heterogeneous, multidimensional drug data sources, together with the innovative deployment of deep learning approaches, helps reduce or prevent the occurrence of adverse drug reactions (ADRs). Deep learning approaches can also be exploited to find replacements for drugs which have side effects or help to diversify the utilization of drugs through drug repurposing.
引用
收藏
页码:1884 / 1901
页数:18
相关论文
共 50 条
  • [1] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Akio Negishi
    Shinji Oshima
    Norimitsu Horii
    Mizue Mutoh
    Naoko Inoue
    Sachihiko Numajiri
    Shigeru Ohshima
    Daisuke Kobayashi
    [J]. Drugs - Real World Outcomes, 2021, 8 : 49 - 61
  • [2] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Negishi, Akio
    Oshima, Shinji
    Horii, Norimitsu
    Mutoh, Mizue
    Inoue, Naoko
    Numajiri, Sachihiko
    Ohshima, Shigeru
    Kobayashi, Daisuke
    [J]. DRUGS-REAL WORLD OUTCOMES, 2021, 8 (01) : 49 - 61
  • [3] An Investigation of Interpretable Deep Learning for Adverse Drug Event Prediction
    Rebane, Jonathan
    Karlsson, Isak
    Papapetrou, Panagiotis
    [J]. 2019 IEEE 32ND INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS), 2019, : 337 - 342
  • [4] MultiGML: Multimodal graph machine learning for prediction of adverse drug events
    Krix, Sophia
    Delong, Lauren Nicole
    Madan, Sumit
    Domingo-Fernandez, Daniel
    Ahmad, Ashar
    Gul, Sheraz
    Zaliani, Andrea
    Froehlich, Holger
    [J]. HELIYON, 2023, 9 (09)
  • [5] Computational drug discovery using deep learning approaches
    Isayev, Olexandr
    Politi, Regina
    Tropsha, Alexander
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [6] MMDRP: drug response prediction and biomarker discovery using multi-modal deep learning
    Taj, Farzan
    Stein, Lincoln D.
    [J]. BIOINFORMATICS ADVANCES, 2024, 4 (01):
  • [7] Advances in Machine Learning Prediction of Toxicological Properties and Adverse Drug Reactions of Pharmaceutical Agents
    Ma, Xiao Hua
    Wang, Rong
    Xue, Yin
    Li, Ze Rong
    Yang, Sheng Yong
    Wei, Yu Quan
    Chen, Yu Zong
    [J]. CURRENT DRUG SAFETY, 2008, 3 (02) : 100 - 114
  • [8] Comprehensive Survey of Recent Drug Discovery Using Deep Learning
    Kim, Jintae
    Park, Sera
    Min, Dongbo
    Kim, Wankyu
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [9] The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation
    David, Guy
    Markowitz, Sara
    Richards-Shubik, Seth
    [J]. AMERICAN ECONOMIC JOURNAL-ECONOMIC POLICY, 2010, 2 (04) : 1 - 25
  • [10] Prediction of intensity and location of seismic events using deep learning
    Nicolis, Orietta
    Plaza, Francisco
    Salas, Rodrigo
    [J]. SPATIAL STATISTICS, 2021, 42